Tag Archive for: Badalyan

USA line art map with a wheat plant icon

State of Celiac Disease in the United States

USA line art map with a wheat plant iconVahe Badalyan, M.D., director of the Children’s National Celiac Disease Program, discusses the current state of celiac disease in the United States, including diagnosis and care among pediatric populations.

Q: In your opinion, how would you classify the state of Celiac Disease among children in the United States as it compares to 10 years ago?

A: Celiac disease in the United States is increasingly recognized as a common disorder of childhood. While this can partly be attributed to improved recognition and more testing by primary care providers, “true incidence” of this immune-mediated disease is also said to be rising, independent of the screening practices.

While there is a larger variety of gluten-free food options available today, these options are often more costly than their gluten-counterparts. Additionally, gluten-free food options are not covered by insurance companies. With inflation and rising food prices, there is a real concern for increased economic burden and food insecurity for the families of children with celiac.

Q: Are there any misnomers about Celiac Disease that you think are important to address?

A: Classic symptoms of celiac disease, including diarrhea and malnutrition, now occur in a minority of celiac patients. There is a rising proportion of milder or asymptomatic presentation at the time of diagnosis. Paired with the fact that most celiac patients identified through mass-screening did not have a family history of celiac disease (~90%) or gastrointestinal symptoms (70%), one may need to have a high index of suspicion for children with atypical presentation, such as neurologic symptoms, iron and vitamin D deficiency.

Q: What excites you about the future of treatment for Celiac Disease?

A: I am encouraged that researchers across the globe are testing new, pharmacologic therapies for celiac disease. Some of the tested compounds, such as latiglutenase or TAK-062 , involve breaking down gluten-using enzymes, while others, such as TAK-101 aim to induce immune tolerance. These compounds are still at the early stages of the long and arduous process of drug development and approval. Current randomized trials typically include adults, although some recently opened enrollment to adolescents. While there are no guarantees, I am cautiously optimistic that in the future we will have pharmacologic, non-dietary treatment options for celiac disease.

Q: How is Children’s National a leader in the field of pediatric Celiac Disease?

A: Concerns about gluten exposure can be quite stressful for our patients and families, which can lead to hypervigilance, anxiety and even depression. We are fortunate to have a full-time psychologist, Shayna Coburn, Ph.D., as part of our Multidisciplinary Celiac Disease Program team. This allows us to treat not only physiological symptoms and concerns associated with celiac disease, but to also evaluate the psychological problems that may arise as a result of the condition.

Human Digestive System Anatomy

Intestinal rehabilitation program demonstrates high survival rates

Human Digestive System AnatomyIn a new study, researchers at Children’s National Hospital analyzed outcomes in children with short-bowel syndrome (SBS), parenteral nutrition dependence (PND) and intestinal failure-associated liver disease (IFALD) who were treated in the Children’s National Intestinal Rehabilitation Program (IRP) from 2007 to 2018.

The study, led by Clarivet Torres, M.D., director of the IRP at Children’s National, reviewed charts of 135 patients with SBS-PND at the time of their enrollment in the IRP. Of these, 89 patients had IFALD, defined as sustained (>2 months) conjugated bilirubin (CB) of ≥2 mg/dl at enrollment and/or abnormal liver biopsy, showing stage two through four fibrosis.

Historically, IFALD was a major cause of mortality among patients with intestinal failure and accounted for the high percentage of pediatric small-bowel transplants. Over the last two decades, outcomes of patients with SBS, PND and IFALD have been improving with creation of intestinal rehabilitation programs.

Recent data from the International Intestinal Failure Registry Pilot Phase showed improved outcomes, with 8% mortality. However, IFALD was the cause of death in 7% and almost 50% of patients were still PN dependent at 12 months of follow-up.

The study at Children’s National reveals normalization of the conjugate hyperbilirubinemia in 99% of the patients with IFALD, over a median time of 9.5 weeks after enrollment, with nontransplant treatment. It also demonstrates a transplant-free survival in 97% of these patients. Although the median percentage of expected bowel length in the study population was only 23% and over half had no ileocecal valve, 81% of patients were successfully weaned from PN over a median time of 5 months of being enrolled in the IRP.

Dr. Torres and her team demonstrate high rates of transplant-free survival and enteral autonomy among SBS children with IFALD who do not have underlying primary motility/genetic disorders.

Despite a high acuity of symptoms and pathology (for example, ultrashort bowel, initially high PND, initial CB >4 mg/dl, significant fibrosis/cirrhosis), they reduced their PN needs relatively quickly and improved IFALD. As one of the larger IRPs in the United States, Children’s National demonstrates high survival rates of patients without the need for liver or intestinal transplantation.

Other Children’s National authors include Vahe Badalyan, M.D., and Parvathi Mohan, M.D.

Torres C, Badalyan V, Mohan P. Twelve-year outcomes of intestinal failure associated liver disease in children with short bowel syndrome: 97% transplant -free survival and 81% enteral autonomy.  Journal of Parenteral and Enteral Nutrition. 2021;1–10. https://doi.org/10.1002/jpen.2112

Vahe Badalyan

Q & A with Celiac Disease Program Director Vahe Badalyan, M.D.

Vahe Badalyan

Vahe Badalyan, M.D., Celiac Disease Program Director

Children’s National Hospital is helping to improve the way pediatric celiac disease is diagnosed and treated. We are proud to announce that Vahe Badalyan, M.D., is the new director of our Celiac Disease Program. Here, Dr. Badalyan tells us more about his work and what makes the Children’s National Celiac Disease Program unique.

Why did you decide to work in this field?

I developed my interest in gastroenterology (GI) from the first months of being a pediatric intern at Inova Fairfax Children’s Hospital. As a resident, I was fortunate to work with and learn from the pediatric GI group led by Ian Leibowitz, M.D., whose mentorship and example inspired me to choose a career in pediatric GI. This field is ripe with so many opportunities to improve the lives of children with very diverse medical conditions, such as celiac disease, inflammatory bowel disease, liver disease and short bowel syndrome, while achieving professional fulfillment and satisfaction. Later, as a pediatric GI fellow at Children’s National, I was fortunate to work with the late John Snyder, M.D., who was in the foundation of developing our celiac program and was so passionate about helping children and families cope with celiac disease. Part of the reason I joined the celiac program is to continue Dr. Snyder’s legacy and to build on his vision to provide excellent care, education and advocacy for our celiac patients.

What is the importance of the multidisciplinary clinic approach for celiac care?

The advantage of the multidisciplinary clinic approach is that patients receive comprehensive care that is tailored to their specific needs. In this setting, medical, nutrition and mental health professionals come together to share the care priorities from their unique perspectives and build a roadmap for the patient that incorporates details of care that may otherwise have been missed. Patient questions pertaining to multiple specialties can be discussed and answered right then and there.

What are some of the most valuable changes or advancements for the program you hope to see in the next couple of years?

We hope to expand the screening and diagnosis of celiac disease in our communities, as many patients with celiac have minimal or no symptoms and go undiagnosed for years. Early detection will allow us to get involved sooner in patients’ lives and make a bigger difference for them. We also hope to be a part of clinical research on celiac disease, including drug therapy trials.

What makes the Celiac Program at Children’s National unique from other programs in the country?

We place a big emphasis on mental health and have a dedicated psychologist working with the children and their families. We also have an excellent celiac educator, dietician, coordinator and nurse practitioner who empower our patients to cope with celiac, lead normal lives and achieve their dreams and aspirations.

Kinsley and Dr. Timothy Kane

Case study: Diagnosing a choledochal cyst in utero

Kinsley and Dr. Timothy Kane

The Feigel family worked with Timothy Kane, M.D., the division chief of general and thoracic surgery at Children’s National, to ensure an accurate diagnosis, coordinate a corrective procedure and support a strong recovery for Kinsley, who just celebrated a 5-month milestone.

On Sept. 30, 2018, Elizabeth Feigel gave birth to a healthy baby girl, Kinsley Feigel. Thirty-two days later, Elizabeth and her husband, Steven Feigel, delighted in another hospital moment: Kinsley, who developed a choledochal cyst in utero, was recovering from a surgical procedure to remove an abnormal bile duct cyst, which also required the removal of her gallbladder.

While the series of events, interspersed with multiple hospital visits, would likely create uneasiness in new parents, the Feigel family worked with Vahe Badalyan, M.D., a gastroenterologist at Children’s National Health System, and with Timothy Kane, M.D., the division chief of general and thoracic surgery at Children’s National, to ensure an accurate diagnosis, coordinate a corrective procedure and support a strong recovery for Kinsley, who just celebrated a 5-month milestone.

One of the keys to Kinsley’s success was close communication between her parents and providers.

Dr. Badalyan and Dr. Kane listened to Elizabeth and Steven’s concerns, explained complex medical terms in lay language, and provided background about Kinsley’s presenting symptoms, risk factors and procedures. Instead of second-guessing the diagnosis, Elizabeth and Steven put their trust into and remained in contact with the medical team, sharing updates about Kinsley at home. This parent-physician partnership helped ensure an accurate diagnosis and tailored treatment for Kinsley.

Here is her story.

An early diagnosis

During a 12-week prenatal ultrasound, Elizabeth discovered that Kinsley had an intra-abdominal cyst. Before Elizabeth came to Children’s National for an MRI, she met with several fetal medicine specialists and had a variety of tests, including an amniocentesis to rule out chromosomal abnormalities, such as Down syndrome.

The team at Children’s National didn’t want to prematurely confirm Kinsley’s choledochal cyst in utero, but additional ultrasounds and an MRI helped narrow the diagnosis to a few conditions.

After Kinsley was born, and despite looking like a healthy, full-term baby, she was transported to the neonatal intensive care unit (NICU) at Children’s National. Dr. Badalyan and Dr. Kane analyzed Kinsley’s postnatal sonogram and found the cyst was bigger than they previously thought. Over a five-day period, the medical team kept Kinsley under their close watch, running additional tests, including an additional sonogram. They then followed up with Kinsley on an outpatient basis to better understand and diagnose her cyst.

Outpatient care

Over the next few weeks, Kinsley, Elizabeth and Steven returned to Children’s National to coordinate multiple exams, ranging from an MRI to a HIDA scan. During this period, Elizabeth and Steven remained in contact with Dr. Badalyan. They heard about Kinsley’s lab results and sent updates about her symptoms, including her stool, which helped the medical team monitor her status.

Meanwhile, Dr. Badalyan and Dr. Kane worked closely with the lab to measure Kinsley’s bilirubin levels. Her presenting symptoms and risk factors, she had jaundice and is a female baby of Asian descent, are associated with both choledochal cysts and biliary atresia.

Over time and with the help of Elizabeth, Steven and the pediatric radiologists, Dr. Badalyan and Dr. Kane confirmed Kinsley had a type 1 choledochal cyst, the most common. Originally, the plan was to operate at three to six months, but Dr. Kane needed to expedite the procedure and operate on Kinsley at one month due to a rise in her bilirubin, a sign of progressive liver disease.

Higher bilirubin levels are common in newborns and remain elevated at about 5 mg/dL after the first few days of birth, but Kinsley’s levels peaked and remained elevated. Instead of her bile flowing into her intestine, her choledochal cyst reduced the flow of bile, which accumulated and started to pour back into her liver. The timing of the surgery was as important as the procedure.

The surgery

On Oct. 31, Halloween, Kinsley had laparoscopic surgery to remove the choledochal cyst. Approximately five to seven patients per year undergo choledochal cyst removal at Children’s National. Smaller infants typically undergo removal of a choledochal cyst using a large incision (or open procedure). Kinsley was the smallest baby at Children’s National to have this type of surgery performed by minimally invasive laparoscopic surgery, which required a few 3-mm incisions – the size of coriander seeds.

Some hospitals use the da Vinci robot, which starts at 8-mm incisions, the size of a small pearl, to conduct this procedure on infants, but this method cannot effectively be done in very small infants. Instead, Dr. Kane prefers to stitch sutures by hand. This technique keeps the incisions small and is technically demanding, but Dr. Kane doesn’t mind (he views this as an advanced technical skill). The goal for this surgery was to cut out the abnormal piece of Kinsley’s common bile duct, comprised of the cyst, remove  this and then sew the bile duct to the small intestine (duodenum), creating a digestive pathway. The new digestive tube allows for bile to flow from her liver through the common hepatic duct, in place of the pathway where the cyst formed, and into her intestine.

Like other surgeries, Dr. Kane needed to adapt the procedure, especially with Kinsley’s size: Taking too much from the bile duct would create a tight space, and could create obstruction, blocking bile, while leaving too much room could create leakage and spilling of the bile, requiring a follow-up surgical procedure within a week or two of the original operation.

Dr. Kane had a few options in mind before he operated. He didn’t know which would be most suitable until the operation, but he remained open and prepared for all three. Adopting this mindset, instead of having one procedure in mind, has helped Dr. Kane with precise and tailored surgeries, which often result in the best procedure and a stronger recovery period for young patients.

After 4.5 hours, the surgery, a two-part procedure – removing the cyst and recreating a functional bile duct – was complete.

Kinsley moved into the recovery unit, where she rested and recovered under close medical supervision for five days. During the first few days, she didn’t have liquids or milk, but she did have two bedside nurses monitoring her status in addition to surgeons making regular rounds. Elizabeth and Steven were relieved: The diagnosis and surgery were over.

Managing risk factors

Before Kinsley left the hospital, Elizabeth and Steven scheduled a follow-up visit to ensure Kinsley was recovering well and avoided risk of infection, such as cholangitis, which can occur suddenly and become chronic.

Following Kinsley’s post-surgical bloodwork in early November, Dr. Badalyan noticed Kinsley’s white blood count was high, signaling infection, and he immediately brought the family back to the hospital. To help her body fight the infection, Kinsley received antibiotics and intravenous fluids. She stayed in the hospital for five days. Fortunately, cholangitis is easy to treat with antibiotics; the key is to detect it early.

Kinsley returned home in time for Thanksgiving. She came back to the hospital for biweekly visits. At this point, she was filling out, reaching a 2-month milestone and nearing a full recovery. She returned for follow-up visits in December and January – and has been healthy ever since. She will continue to make routine visits during her first year to ensure her white blood count remains in a healthy range.

Investing in youth resilience

Dr. Badalyan and Dr. Kane envision a healthy future for Kinsley. They don’t expect she’ll need additional operations. Her parents are also looking on the bright side: Since gallbladders aren’t essential for survival or long-term health outcomes, and since many people can easily live without them, Kinsley may be at an advantage. Elizabeth thinks Kinsley may be more cautious about lifestyle choices to support living without a gallbladder, which also support longevity.

Another perspective noted by Dr. Badalyan and Dr. Kane is Kinsley’s resilience factor. Having the surgery earlier brought unique challenges, but her age makes it easier for Kinsley to bounce back as her body rapidly develops. Her tissues were healthy, compared to adult patients undergoing surgery with chronic liver problems or heart disease, which puts her at an advantage for a faster healing process. Dr. Badalyan also mentions that while it’s good for her Kinsley and her family to continue to monitor risks for infections, she won’t have gallstones.

Elizabeth also started to notice something that Kinsley’s doctors likely wouldn’t pick up on: Her personality seems to be a result of her hospital experience and stay. Kinsley’s an easy baby. She eats well and sleeps well, which Elizabeth credits to being around clinicians and to learning the art of self-soothing, a skill she likely acquired while recovering from surgery.

This month, Kinsley has another adventure. She’ll travel with her parents to visit extended family in Seattle, Napa Valley, Calif. and West Virginia. She has several relatives and family friends, all of whom are looking forward to meeting her.